Article

Received 17.10.2025

Revised 14.01.2026

Accepted 25.02.2026

Retrieved from Vol. 2, No. 1, 2026

Pages 49 -60

Lisiecka, M.Z. , Sybilski, A.J. , & Luczak, J. (2026). A comprehensive approach to the treatment of atopic dermatitis in children with food sensitisation. Journal of Human Biology and Clinical Medicine, 2(1), 49-60. https://doi.org/10.63621/jhbcm/1.2026.49

A comprehensive approach to the treatment of atopic dermatitis in children with food sensitisation

Maria Zofia Lisiecka, Adam J. Sybilski, Joanna Luczak

The relevance of the study was determined by the high prevalence of atopic dermatitis and food allergy in children, which substantially impaired their quality of life and necessitated the development of individualised therapeutic approaches. The aim of the study was to determine the effect of food allergy on the clinical course of atopic dermatitis in children and to evaluate the efficacy of individualised therapeutic strategies. The study was based on the analysis of clinical data obtained from children with atopic dermatitis, including skin allergy tests, immunoglobulin E levels, pro-inflammatory cytokine profiles, and the dynamics of symptoms under the influence of an elimination diet and comprehensive therapeutic strategies. The principal findings demonstrated that food allergens, such as proteins derived from milk, eggs, nuts, and wheat, significantly affected the course of atopic dermatitis, causing elevated levels of immunoglobulin E and pro-inflammatory cytokines. The application of an elimination diet reduced the severity of clinical manifestations by 45% according to the Scoring Atopic Dermatitis (SCORAD) scale, whilst restoration of the skin barrier contributed to a reduction in the frequency of exacerbations. Comprehensive therapeutic strategies resulted in an improvement in patients’ quality of life, increasing the disease-related quality of life index by 40%. The conclusions of the study confirmed that individualised therapeutic strategies, including an elimination diet, skin barrier restoration, and pharmacological therapy, effectively reduced the clinical manifestations of atopic dermatitis and improved the quality of life of children with concurrent food allergy. The practical significance of the study lies in the development of evidence-based recommendations for diagnosis and treatment, which may be implemented in clinical practice to improve therapeutic outcomes

genetic factors, phenotypes, skin barrier function, allergology, immunological mechanisms, dietary therapy
  1. Kanda N, Hoashi T, Saeki H. Nutrition and atopic dermatitis. J Nippon Med Sch. 2021;88(3):171–7. DOI: 10.1272/jnms.JNMS.2021_88-317
  2. Mehta Y, Fulmali DG. Relationship between atopic dermatitis and food allergy in children. Cureus. 2022;14(12):e33160. DOI: 10.7759/cureus.33160
  3. Korçari G, Lika M, Trebicka A. The seasonal risk of food allergies in Albania: Focus on fish and crustaceans. Int J Sci Dev Res. 2024;9(6): 427–35.
  4. Seker A, Qirko-Gurakuqi A, Tabaku M, Javate KRP, Rathwell I. Maternal atopic conditions and autism spectrum disorder: A systematic review. Eur Child Adolesc Psychiatry. 2024;33(11):3727–37. DOI: 10.1007/s00787-023-02285-7
  5. Asllani J, Mitsias D, Konstantinou G, Mesonjesi E, Xhixha F, Shehu E, et al. Adverse events in children and adolescents undergoing allergen immunotherapy for respiratory allergies – report from the Allergen Immunotherapy Adverse Events Registry (ADER), a European Academy of Allergy and Clinical Immunology taskforce. Clin Transl Allergy. 2023;13(6):e12250. DOI: 10.1002/clt2.12250
  6. Jafferany M, Jorgaqi E. Psychodermatology in Balkans: Knowledge, awareness, and practice patterns of dermatologists in Albania. Dermatol Ther. 2020;33(3):e13286. DOI: 10.1111/dth.13286
  7. Tramper-Stranders G, Ambrożej D, Arcolaci A, Atanaskovic-Markovic M, Boccabella C, Bonini M, et al. Dangerous liaisons: Bacteria, antimicrobial therapies, and allergic diseases. Allergy. 2021;76(11):3276–91. DOI: 10.1111/all.15046
  8. Mocanu M, Vâță D, Alexa AI, Trandafir L, Patrașcu AI, Hâncu MF, et al. Atopic dermatitis – beyond the skin. Diagnostics. 2021;11(9):1553. DOI: 10.3390/diagnostics11091553
  9. Wollenberg A, Werfel T, Ring J, Ott H, Gieler U, Weidinger S. Atopic dermatitis in children and adults – diagnosis and treatment. Dtsch Arztebl Int. 2023;120(13):224–34. DOI: 10.3238/arztebl.m2023.0011
  10. Trikamjee T, Comberiati P, D’Auria E, Peroni D, Zuccotti GV. Nutritional factors in the prevention of atopic dermatitis in children. Front Pediatr. 2021;8:577413. DOI: 10.3389/fped.2020.577413
  11. University Hospital Düsseldorf [Internet]. [cited 2025 May 23]. Available from: https://www.uniklinik-duesseldorf.de
  12. St George’s University Hospitals NHS Foundation Trust. Paediatric services [Internet]. [cited 2025 February 24]. Available from: https://www.stgeorges.nhs.uk/
  13. Instytut “Pomnik – Centrum Zdrowia Dziecka” [Internet]. [cited 2025 April 7]. Available from: https://www.czd.pl
  14. Milan Pediatric Clinical Hospital [Internet]. [cited 2025 March 11]. Available from: https://www.policlinico.mi.it
  15. The World Medical Association. Declaration of Helsinki: Ethical Principles for Medical Research Involving Human Subjects [Internet]. [cited 2025 June 8]. Available from: https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/
  16. Regulation (EU) 2016/679 of the European Parliament and of the Council. On the Protection of Natural Persons with Regard to the Processing of Personal Data and on the Free Movement of Such Data, and Repealing Directive 95/46/EC (General Data Protection Regulation) [Internet]. 2016 April 27 [cited 2025 May 24]. Available from: https://eur-lex.europa.eu/eli/reg/2016/679/oj
  17. Park KY, Han HS, Park JW, Kwon HH, Park GH, Seo SJ. Exosomes derived from human adipose tissue-derived mesenchymal stem cells for the treatment of dupilumab-related facial redness in patients with atopic dermatitis: A report of two cases. J Cosmet Dermatol. 2022;21(2):844–9. DOI: 10.1111/jocd.14153
  18. Virolainen SJ, Satish L, Biagini JM, Chaib H, Chang WC, Dexheimer PJ, et al. Filaggrin loss-of-function variants are associated with atopic dermatitis phenotypes in a diverse, early-life prospective cohort. JCI Insight. 2024;9(9):e178258. DOI: 10.1172/jci.insight.178258
  19. Moosbrugger-Martinz V, Leprince C, Méchin MC, Simon M, Blunder S, Gruber R, et al. Revisiting the roles of filaggrin in atopic dermatitis. Int J Mol Sci. 2022;23(10):5318. DOI: 10.3390/ijms23105318
  20. Belmesk L, Muntyanu A, Cantin E, AlHalees Z, Jack CS, Le M, et al. Prominent role of type 2 immunity in skin diseases: beyond atopic dermatitis. J Cutan Med Surg. 2022;26(1):33–49. DOI: 10.1177/12034754211027858
  21. Zhang DJ, Hao F, Qian T, Cheng HX. Expression of helper and regulatory T cells in atopic dermatitis: A meta-analysis. Front Pediatr. 2022;10:777992. DOI: 10.3389/fped.2022.777992
  22. Lyubchenko T, Collins HK, Goleva E, Leung DY. Skin tape sampling technique identifies proinflammatory cytokines in atopic dermatitis skin. Ann Allergy Asthma Immunol. 2021;126(1):46–53. DOI: 10.1016/j.anai.2020.08.397
  23. Torres T, Gonçalo M, Paiva Lopes MJ, Claro C, Ramos L, Selores M, et al. Portuguese recommendations for the treatment of atopic dermatitis with biologic therapy and JAK inhibitors in adult patients. Drugs Context. 2021;10:2021-9-5. DOI: 10.7573/dic.2021-9-5
  24. Kulthanan K, Tuchinda P, Nitiyarom R, Chunharas A, Chantaphakul H, Aunhachoke K, et al. Clinical practice guidelines for the diagnosis and management of atopic dermatitis. Asian Pac J Allergy Immunol. 2021;39(3):145–55. DOI: 10.12932/AP-010221-1050
  25. Mitchell AE, Morawska A, Casey E, Forbes E, Filus A, Fraser J, et al. Brief parenting intervention (Triple P) for families of children with eczema: A randomized controlled trial. J Pediatr Psychol. 2024;49(6):429–41. DOI: 10.1093/jpepsy/jsae023
  26. Schade RP, Van Ieperen-Van Dijk AG, Van Reijsen FC, Versluis C, Kimpen JL, Knol EF, et al. Differences in antigen-specific T-cell responses between infants with atopic dermatitis with and without cow’s milk allergy: Relevance of TH2 cytokines. J Allergy Clin Immunol. 2000;106(6):1155–62. DOI: 10.1067/mai.2000.110802
  27. Hoyer A, Rehbinder EM, Färdig M, Asad S, Lødrup Carlsen KC, Endre KMA, et al. Filaggrin mutations in relation to skin barrier and atopic dermatitis in early infancy. Br J Dermatol. 2022;186(3):544–52. DOI: 10.1111/bjd.20831
  28. Eichenfield LF, Boguniewicz M, Lauren CT, Leung DY, Levy ML, Schneider LC, et al. Systemic therapy for atopic dermatitis in children and adolescents: A US expert consensus. Dermatology. 2024;240(5–6):897–909. DOI: 10.1159/000540920
  29. Courtney A, Su JC. The psychology of atopic dermatitis. J Clin Med. 2024;13(6):1602. DOI: 10.3390/jcm13061602
  30. Jang YH, Choi E, Lee H, Woo J, Park S, Noh Y, et al. Long-term use of oral corticosteroids and safety outcomes for patients with atopic dermatitis. JAMA Netw Open. 2024;7(7):e2423563. DOI: 10.1001/jamanetworkopen.2024.23563
  31. Kim JE, Lee J, Huh YJ, Kim K, Chaparala V, Krueger JG, et al. Genomic profiling of the overlap phenotype between psoriasis and atopic dermatitis. J Invest Dermatol. 2024;144(1):43–52. DOI: 10.1016/j.jid.2023.06.194
  32. Lee HH, Patel KR, Singam V, Rastogi S, Silverberg JI. A systematic review and meta-analysis of the prevalence and phenotype of adult-onset atopic dermatitis. J Am Acad Dermatol. 2019;80(6):1526–32. DOI: 10.1016/j.jaad.2018.05.1241